NeoGenomics Stock - Thursday technicals and trading picture
18.06.2026 - 20:39:43 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:30 UTC. Details in the imprint.
NeoGenomics (US64049M2098) is a US-based cancer diagnostics group listed on the Nasdaq. With no new company-specific filings or major news from primary sources on Thursday, the focus for investors shifts to the stock's recent trading range and technical picture.
All news and data on NeoGenomics stock
Historical announcements, price data and background information on NeoGenomics stock are bundled on the ad hoc news topic page and the company’s investor-relations site.
Recent trading and volatility
NeoGenomics shares continue to trade on the Nasdaq Global Select Market under the ticker NEO, with an average daily volume of several hundred thousand shares over recent weeks according to Nasdaq trading data.
The stock remains well below its 2021 highs after a multi-year derating, but has stabilized in a broad range in recent months as investors reassess growth prospects in oncology testing.
Key technical reference points
Chart data from MarketWatch show that NeoGenomics shares are trading below their longer-term peak but above 52-week lows, leaving the stock in a mid-range consolidation zone.
Against this backdrop, short-term moves in the broader health-care and diagnostics sector, as well as shifts in risk appetite on the Nasdaq, remain important drivers for day-to-day price fluctuations in NeoGenomics shares.
How NeoGenomics makes money
NeoGenomics generates revenue primarily from oncology-focused clinical laboratory services, including comprehensive genomic profiling, flow cytometry, cytogenetics and immunohistochemistry tests used by oncologists and biopharma partners to diagnose and monitor cancer.
Where the stock trades today
The shares of NeoGenomics (US64049M2098) trade on the Nasdaq; the latest available quote and market capitalization can be obtained from the Nasdaq and major financial data providers.
Key facts on NeoGenomics stock
- Company: NeoGenomics Inc.
- ISIN: US64049M2098
- WKN: A14RX2
- Ticker: NEO
- Venue: Nasdaq
- Market cap: Market capitalization data are available from major financial information providers.
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: Not a member of the S&P 500 or Nasdaq-100
- Next earnings date: The next quarterly earnings date has not yet been officially scheduled.
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
